Status:

COMPLETED

Urine Cytology and Utility in Bladder Recurrence

Lead Sponsor:

Corewell Health East

Conditions:

Bladder Cancer

Eligibility:

All Genders

18+ years

Brief Summary

Review bladder cancer patients and form a database in regards to urine cytology.

Detailed Description

In 2008 there was an estimated 68,810 new cases of bladder cancer, and 14,100 deaths. On the list of morbidity due to cancer, bladder cancer ranks number nine, yet is number one in dollars spent per c...

Eligibility Criteria

Inclusion

  • Bladder cancer patients from Dr. Jay Hollander's private practice.

Exclusion

  • Patients with diagnosis of bladder cancer without initial cytology available.
  • Patients who received outside nephrectomy or cystectomy without pathology available.
  • Those who had recurrence without cytology results available.
  • Those who were followed by Dr Hollander and another urologist in which records are missing for a significant number of follow ups.

Key Trial Info

Start Date :

September 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2010

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT00971256

Start Date

September 1 2009

End Date

September 1 2010

Last Update

November 23 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.